Particularly, in the U118MG GBM cell line, TG2 expression promotes resistance to lomustine but not to TMZ [23], whereas Yuan and colleagues demonstrated that inhibition of TG2 enhanced sensitivity to carmustine [160,161]. This evidence concerns the gene TGM2 and glioblastoma.